


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:31Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406379" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406379</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>perimed</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Perioper Med (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Perioper Med (Lond)</journal-id><journal-id journal-id-type="pmc-domain-id">2293</journal-id><journal-id journal-id-type="pmc-domain">perimed</journal-id><journal-title-group><journal-title>Perioperative Medicine</journal-title></journal-title-group><issn pub-type="epub">2047-0525</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406379</article-id><article-id pub-id-type="pmcid-ver">PMC12406379.1</article-id><article-id pub-id-type="pmcaid">12406379</article-id><article-id pub-id-type="pmcaiid">12406379</article-id><article-id pub-id-type="pmid">40898296</article-id><article-id pub-id-type="doi">10.1186/s13741-025-00577-x</article-id><article-id pub-id-type="publisher-id">577</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Endovascular embolization for ruptured intracranial aneurysms: efficacy and effects on oxidative stress levels</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Yang</surname><given-names initials="S">Sheng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Wu</surname><given-names initials="S">Shanwu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ouyang</surname><given-names initials="G">Guang</given-names></name><address><email>Ouyangguang6699@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01dr2b756</institution-id><institution-id institution-id-type="GRID">grid.443573.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 2448</institution-id><institution>Department of Neurosurgery, </institution><institution>Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan
, </institution></institution-wrap>Hubei Province, 442000 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00e4hrk88</institution-id><institution-id institution-id-type="GRID">grid.412787.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9868 173X</institution-id><institution>Department of Neurosurgery, </institution><institution>Puren Hospital Affiliated to Wuhan University of Science and Technology Qingshan District, </institution></institution-wrap>No. 1, Benxi Street, Wuhan Hubei Province, 430081 China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">478634</issue-id><elocation-id>93</elocation-id><history><date date-type="received"><day>23</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>7</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="13741_2025_Article_577.pdf"/><abstract id="Abs1"><sec><title>Objective</title><p id="Par5">This study aimed to investigate the efficacy of endovascular embolization in treating ruptured intracranial aneurysms (RIAs).</p></sec><sec><title>Methods</title><p id="Par6">RIA patients (<italic toggle="yes">n</italic>&#8201;=&#8201;89) were grouped according to different surgical methods. The control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42) received aneurysm clipping surgery, whereas the observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47) received endovascular embolization. The National Institutes of Health Stroke Scale (NIHSS) was used to assess neurological function pre-treatment and at 7&#160;days post-treatment. Oxidative stress status, including superoxide dismutase (SOD) levels and serum malondialdehyde (MDA) levels, was compared between the two groups pre-treatment and at 7&#160;days post-treatment. Intraoperative bleeding, operative time, and hospitalization time were compared between the two groups. Vascular endothelial function, including von Willebrand factor (vWF), endothelin-1 (ET-1), and nitric oxide (NO), was evaluated pre-treatment and 3&#160;months post-treatment. Postoperative complications and surgical outcomes were observed.</p></sec><sec><title>Results</title><p id="Par7">After treatment, compared to the control group, the observation group had lower NIHSS scores, higher SOD levels, and lower MDA levels, with statistically significant differences (all <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001); the observation group also had less intraoperative bleeding, shorter operation times, and shorter hospital stays, along with lower vWF and ET-1 levels, higher NO levels, and statistically significant differences (all <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). The incidence of postoperative complications was lower in the observation group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;=&#8201;0.048). The therapeutic effect was better in the observation group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;=&#8201;0.041).</p></sec><sec><title>Conclusion</title><p id="Par8">Compared with microscopic aneurysm clipping, endovascular embolization offers better efficacy for patients with RIA and causes less vascular endothelial damage.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Microscopic aneurysm clipping</kwd><kwd>Endovascular embolization</kwd><kwd>Intracranial aneurysm</kwd><kwd>Oxidative stress</kwd><kwd>Vascular endothelial function</kwd><kwd>Efficacy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par9">A cerebral aneurysm, also referred to as an intracranial aneurysm (IA), is a localized abnormal expansion of a cerebral artery resulting from the weakening of the vessel&#8217;s inner muscular layer (Li et al. <xref ref-type="bibr" rid="CR13">2023</xref>). Once an aneurysm forms, it may remain stable, enlarge, or rupture. Predicting the progression of an IA is highly challenging. If rupture occurs, it typically results in subarachnoid hemorrhage (SAH), predominantly affecting younger individuals and leading to significant outcomes such as mortality, disability, and a considerable socioeconomic impact (Morel et al. <xref ref-type="bibr" rid="CR15">2022</xref>). Oxidative stress refers to the buildup of reactive oxygen species, which disrupts cellular balance by chemically modifying and damaging key biomolecules, including proteins, lipids, and DNA (Ping et al. <xref ref-type="bibr" rid="CR17">2020</xref>).</p><p id="Par10">However, SAH resulting from ruptured intracranial aneurysms (RIAs) not only causes direct mechanical damage but also induces vascular endothelial dysfunction through oxidative stress reactions, subsequently triggering secondary injuries such as cerebral vasospasm and cerebral edema (Tian et al. <xref ref-type="bibr" rid="CR25">2023</xref>; Wu et al. <xref ref-type="bibr" rid="CR28">2023</xref>). Studies have shown that a large number of hemoglobin degradation products after SAH can activate NADPH oxidase, leading to excessive production of reactive oxygen species, which disrupt the tight junctions between vascular endothelial cells and increase blood&#8211;brain barrier permeability (Wu et al. <xref ref-type="bibr" rid="CR28">2023</xref>; Xu et al. <xref ref-type="bibr" rid="CR30">2021</xref>). Meanwhile, oxidative stress can further exacerbate vasoconstriction and inflammatory responses by inhibiting endothelial nitric oxide synthase activity and reducing nitric oxide (NO) production (Xu et al. <xref ref-type="bibr" rid="CR30">2021</xref>; Hernandez-Navarro et al. <xref ref-type="bibr" rid="CR8">2024</xref>).</p><p id="Par11">Currently, RIAs are primarily treated through invasive procedures, including surgical clipping and various endovascular techniques such as coiling (with or without stent deployment) and the placement of flow diverters (Li et al. <xref ref-type="bibr" rid="CR12">2024</xref>). Endovascular intervention for both RIAs and unruptured IAs has become a standard and increasingly prevalent approach over recent years (Opitz et al. <xref ref-type="bibr" rid="CR16">2023</xref>). Endovascular treatment approaches encompass various techniques, such as basic coiling, stent- or balloon-assisted coiling, flow-diversion stent insertion, liquid embolization, and the occlusion of the parent vessel (Scerrati et al. <xref ref-type="bibr" rid="CR20">2021</xref>). This minimally invasive method avoids direct manipulation of brain tissue and arteries. Additionally, findings from the International Subarachnoid Aneurysm Trial have demonstrated a 7.4% absolute reduction in the risk of dependence, supporting the efficacy of endovascular treatment (Wang et al. <xref ref-type="bibr" rid="CR27">2023</xref>). Taken together, evaluating the impact of endovascular embolization on oxidative stress levels not only helps to reveal its potential mechanisms for repairing brain injury but also provides a theoretical basis for optimizing treatment strategies.</p><p id="Par12">The aim of this study was to investigate the efficacy of endovascular embolization in the treatment of RIAs and to assess its effect on patients&#8217; oxidative stress levels. By analyzing changes in serum markers of oxidative stress and vascular endothelial function indicators before and after surgery, we aim to explore the regulatory effect of this procedure on the oxidative stress-endothelial dysfunction pathway. We hope that this study will provide new intervention targets for improving the prognosis of patients with RIA.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Ethics statement</title><p id="Par13">This study was a retrospective analysis approved by the Ethics Committee of Puren Hospital Affiliated to Wuhan University of Science and Technology, and patient informed consent was waived.</p></sec><sec id="Sec4"><title>General data</title><p id="Par14">Sample size estimation was performed using G*Power 3.1.9.7 (University of D&#252;sseldorf, Germany) based on statistical efficiency, with power&#8201;=&#8201;0.80, <italic toggle="yes">&#945;</italic>&#8201;=&#8201;0.05, effect size&#8201;=&#8201;0.65, and number of groups&#8201;=&#8201;2. The analysis indicated a minimum required sample size of 76 cases. Considering a 15% sample attrition rate, a total of 89 research subjects were ultimately included. A retrospective collection of 89 patients with RIA admitted to Puren Hospital Affiliated to Wuhan University of Science and Technology from May 2020 to May 2023 was conducted. According to different surgical methods, they were divided into two groups. The control group consisted of 42 patients who underwent aneurysm clipping surgery under microscope guidance, whereas the observation group included 47 patients who received endovascular embolization treatment.</p></sec><sec id="Sec5"><title>Exclusion and inclusion criteria</title><sec id="Sec6"><title>Inclusion criteria</title><p id="Par15">The inclusion criteria are patients who met the diagnostic criteria for intracranial aneurysms and were diagnosed with RIAs via computed tomography (CT) or magnetic resonance imaging (MRI) (Santarosa et al. <xref ref-type="bibr" rid="CR19">2020</xref>), patients who were first-time visitors, patients with aneurysm diameters ranging from 3.0 to 20.0&#160;mm, and patients who received treatment within 72&#160;h of onset.</p></sec><sec id="Sec7"><title>Exclusion criteria</title><p id="Par16">The exclusion criteria are patients with coagulation disorders, patients with other malignant diseases, patients with immune system disorders, patients with severe hepatic and renal insufficiency, patients with a history of major trauma and surgery within the last 3&#160;months, patients with contraindications to anesthesia or surgery, and patients with congenital cerebral vascular malformations.</p></sec></sec></sec><sec id="Sec8"><title>Methods</title><p id="Par17">After admission, both groups of patients received conventional treatment for cerebral hemorrhage, including dehydration to reduce intracranial pressure, hemostasis, and nerve nutrition. The surgeries in both groups were performed by the same surgical team.</p><sec id="Sec9"><title>Anesthesia method</title><p id="Par18">Patients were reminded to fast for 8&#160;h before surgery. On the morning of surgery, patients were routinely administered antihypertensive medications. Thirty minutes before surgery, 0.1&#160;g of sodium phenobarbital and 0.5&#160;g of atropine were injected intramuscularly. Upon entering the operating room, patients&#8217; vital signs were observed and recorded using a multifunctional electrocardiogram monitor. After 5&#160;min of mask oxygenation, rapid intravenous induction was performed. First, 0.04&#160;mg&#183;kg<sup>&#8722;1</sup> of midazolam injection was administered intravenously, followed by 0.6&#160;&#956;g&#183;kg<sup>&#8722;1</sup> of sufentanil in two doses (0.4&#160;&#956;g&#183;kg<sup>&#8722;1</sup> initially, then 0.2&#160;&#956;g&#183;kg<sup>&#8722;1</sup> after 1&#160;min), and then 0.3&#160;mg&#183;kg<sup>&#8722;1</sup> of cisatracurium. Once the patient&#8217;s mandibular muscles were relaxed, 40&#8211;100&#160;mg of propofol was administered intravenously based on the patient&#8217;s blood pressure level. After 1&#160;min, a tracheal tube with an internal diameter of 7.0&#8211;7.5&#160;mm was inserted orally according to the patient&#8217;s body type. After successful intubation, the tube was immediately connected to an anesthesia machine for mechanical ventilation in both groups, with a frequency set at 12 breaths per minute and a tidal volume of 10&#160;mL&#183;kg<sup>&#8722;1</sup>. After the tube was properly secured, the patient&#8217;s breathing was observed again to check for any displacement of the intubation. During the surgical procedure, both groups received continuous infusion of 4&#8211;6&#160;mg&#183;kg<sup>&#8722;1</sup>&#183;h<sup>&#8722;1</sup> of propofol, 3&#160;&#956;g&#183;kg<sup>&#8722;1</sup>&#183;h<sup>&#8722;1</sup> of remifentanil, and 0.12&#160;mg&#183;kg<sup>&#8722;1</sup>&#183;h<sup>&#8722;1</sup> of cisatracurium to maintain anesthesia. Ten minutes before the end of surgery, anesthesia maintenance was stopped, and 0.1&#160;&#956;g&#183;kg<sup>&#8722;1</sup> of sufentanil was administered intravenously.</p><p id="Par19">The control group underwent microscopic aneurysm clamping. The patients underwent tracheal intubation and general anesthesia. The aneurysm was determined with reference to preoperative cranial CT angiography (CTA) or cerebral angiography. After removing the bone flap and carefully separating the skin flap to expose the dura mater, the location of the aneurysm and the surrounding blood vessels and nerves was clarified with the assistance of the microscope. An appropriate aneurysm clip was selected to isolate the aneurysm neck, and hemostasis was achieved by clamping the aneurysm neck at the designated position. The aneurysm neck was then carefully separated using the corresponding aneurysm clip, and the hemorrhage was stopped by clamping at the appropriate position of the aneurysm neck.</p><p id="Par20">The observation group received endovascular embolization treatment. The patient was positioned flat, and general anesthesia with endotracheal intubation was administered. The anesthetic effect was closely observed throughout the operation, and systemic heparinization was applied. The aneurysm size and neoplasia neck width were determined with the assistance of whole cerebral angiography, and a microguidewire was then introduced into the parent artery, and a secondary angiography was performed to determine the specific location of both the microguidewire and the aneurysm. Next, a suitable spring coil was placed around the microguidewire at the appropriate position, and the exposed metal part of the spring coil was connected to the positive and negative poles of the release device with a percutaneous perforation needle, with the voltage adjusted to the appropriate level. Finally, the microguidewire was withdrawn under fluoroscopic guidance, completing the procedure.</p><p id="Par21">Both groups received postoperative intravenous infusion of nimodipine (Bayer Schering Pharma AG, National Medical Products Administration Approval Number J20100002) at a dose of 0.8&#8211;1.0&#160;mg/h for 5&#8211;7&#160;days to prevent vasospasm. Lumbar puncture for continuous drainage was performed 48&#160;h after surgery based on the patient&#8217;s condition. Patients with a clear history of seizures may receive phenytoin for antiepileptic treatment (Chumnanvej et al. <xref ref-type="bibr" rid="CR5">2007</xref>).</p></sec><sec id="Sec10"><title>Observation parameters</title><p id="Par22">Neurological function was assessed by using the National Institutes of Health Stroke Scale (NIHSS) (Kwah and Diong <xref ref-type="bibr" rid="CR11">2014</xref>) before and on day 7 post-treatment in both groups, which includes 11 scoring items (level of consciousness, gaze, visual fields, facial palsy, upper/lower limb movement, limb ataxia, sensation, language, dysarthria, neglect), with a maximum score of 40 points. A lower score on the NIHSS indicates better neurological function.</p><p id="Par23">Five milliliters of fasting venous blood was collected from both groups pre-treatment and 7&#160;days post-treatment, using heparin sodium anticoagulant tubes (containing 10 U/ml of heparin). Samples were centrifuged at 1000&#8201;&#215;&#8201;g (4&#160;&#176;C) for 10&#160;min within 2&#160;h of collection, and the upper plasma layer was separated, aliquoted into sterile EP tubes, and stored at&#8201;&#8722;&#8201;80&#160;&#176;C for later analysis, avoiding repeated freeze&#8211;thaw cycles. Plasma superoxide dismutase (SOD) activity was detected using the xanthine oxidase method (ultraviolet spectrophotometry, 560&#160;nm wavelength), and plasma malondialdehyde (MDA) levels were detected using the thiobarbituric acid colorimetric method (ultraviolet spectrophotometry, 532&#160;nm wavelength). SOD and MDA kits were purchased from Wuhan Yacoy Biotechnology Co., Ltd., with product numbers KTB1030 and KTB9050, respectively, and operations were performed strictly according to the instructions (Leon and J. and C.R. Borges, xxxx; Feoli et al. <xref ref-type="bibr" rid="CR6">2014</xref>).</p><p id="Par24">Intraoperative bleeding, operative time, and hospitalization time were compared between the two groups, and complications arising in both groups were recorded.</p><p id="Par25">Four milliliters of venous blood samples was collected from both groups before and 3&#160;months post-treatment, using vacuum blood collection tubes containing sodium citrate anticoagulant (3.8% concentration). Samples were centrifuged at 1000&#8201;&#215;&#8201;g (4&#160;&#176;C) for 10&#160;min within 2&#160;h of collection, and the upper plasma layer was separated, transferred to sterile EP tubes, and stored at&#8201;&#8722;&#8201;80&#160;&#176;C for later analysis, avoiding repeated freeze&#8211;thaw cycles. The levels of Von Willebrand factor (vWF) were measured using enzyme-linked immunosorbent assay, endothelin-1 (ET-1) levels by radioimmunoassay, and NO levels by chemical colorimetric assay. The vWF kit was purchased from Wuhan Baiyixin Biotechnology Co., Ltd., with product number TD711268; the ET-1 kit was purchased from Wuhan Yipu Biotechnology Co., Ltd., with product number E-EL-H0064; and the NO kit was purchased from Wuhan Yacoy Biotechnology Co., Ltd., with product number KTB1400. Operations were performed strictly according to the instructions (Tabatabaei and Ahmed <xref ref-type="bibr" rid="CR23">2022</xref>; Benson et al. <xref ref-type="bibr" rid="CR3">1991</xref>; Shaw et al. <xref ref-type="bibr" rid="CR21">2000</xref>; Goshi et al. <xref ref-type="bibr" rid="CR7">2019</xref>).</p><p id="Par26">The efficacy 3&#160;months after surgery in both groups was compared and assessed by two non-surgical neuroradiologists who jointly discussed and determined the results. Clinical efficacy evaluation criteria referred to the &#8220;Chinese Expert Consensus on Endovascular Interventional Treatment of Intracranial Aneurysms (2013).&#8221; No residual aneurysm was detected on imaging as markedly effective, significant symptom improvement with a&#8201;&gt;&#8201;50% reduction in postoperative embolization degree as effective, and no symptom improvement or even coma as ineffective (Zhu et al. <xref ref-type="bibr" rid="CR32">2022</xref>). The total effective rate was calculated as the number of cases categorized as markedly effective or effective divided by the total number of cases, multiplied by 100%.</p></sec><sec id="Sec11"><title>Statistical analyses</title><p id="Par27">GraphPad Prism 8.0 software was applied to process the data. The chi-square test was adopted for the categorical data, which was expressed as a percentage (%). Measurement data were expressed as mean&#8201;&#177;&#8201;standard deviation and analyzed using an independent samples <italic toggle="yes">t</italic>-test or a paired sample <italic toggle="yes">t</italic>-test. The difference was regarded as statistically significant if <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>General information</title><p id="Par28">The control group consisted of 22 males and 20 females, with an average age of (47.64&#8201;&#177;&#8201;3.46) years. The locations of intracranial aneurysms were 23 cases in the anterior communicating artery, 5 cases in the posterior communicating artery, 10 cases in the middle cerebral artery, and 4 cases in the anterior cerebral artery. The observation group consisted of 25 males and 22 females, with an average age of (48.17&#8201;&#177;&#8201;3.77) years. The locations of intracranial aneurysms were 21 cases in the anterior communicating artery, 6 cases in the posterior communicating artery, 13 cases in the middle cerebral artery, and 7 cases in the anterior cerebral artery. There were no significant differences in general information, such as gender, age, and body mass index, between the two groups (<italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Comparison of general information between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gender</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.939</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Male</td><td align="left" colspan="1" rowspan="1">22 (52.38)</td><td align="left" colspan="1" rowspan="1">25 (53.19)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Female</td><td align="left" colspan="1" rowspan="1">20 (47.62)</td><td align="left" colspan="1" rowspan="1">22 (46.81)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">47.64&#8201;&#177;&#8201;3.46</td><td align="left" colspan="1" rowspan="1">48.17&#8201;&#177;&#8201;3.77</td><td align="left" colspan="1" rowspan="1">0.496</td></tr><tr><td align="left" colspan="1" rowspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">22.45&#8201;&#177;&#8201;3.09</td><td align="left" colspan="1" rowspan="1">22.17&#8201;&#177;&#8201;3.02</td><td align="left" colspan="1" rowspan="1">0.664</td></tr><tr><td align="left" colspan="1" rowspan="1">Location of intracranial aneurysms</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.298</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anterior communicating artery</td><td align="left" colspan="1" rowspan="1">23 (54.76)</td><td align="left" colspan="1" rowspan="1">21 (44.68)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Posterior communicating artery</td><td align="left" colspan="1" rowspan="1">5 (11.90)</td><td align="left" colspan="1" rowspan="1">6 (12.77)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Middle cerebral artery</td><td align="left" colspan="1" rowspan="1">10 (23.81)</td><td align="left" colspan="1" rowspan="1">13 (27.66)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anterior cerebral artery</td><td align="left" colspan="1" rowspan="1">4 (9.52)</td><td align="left" colspan="1" rowspan="1">7 (14.89)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Comorbid underlying diseases</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hypertension</td><td align="left" colspan="1" rowspan="1">12 (28.57)</td><td align="left" colspan="1" rowspan="1">10 (21.28)</td><td align="left" colspan="1" rowspan="1">0.426</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diabetes</td><td align="left" colspan="1" rowspan="1">9 (21.43)</td><td align="left" colspan="1" rowspan="1">11 (23.40)</td><td align="left" colspan="1" rowspan="1">0.824</td></tr><tr><td align="left" colspan="1" rowspan="1">Hunt-Hess grading</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.944</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Grade I</td><td align="left" colspan="1" rowspan="1">12 (28.57)</td><td align="left" colspan="1" rowspan="1">13 (27.66)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Grade II</td><td align="left" colspan="1" rowspan="1">22 (52.38)</td><td align="left" colspan="1" rowspan="1">25 (53.19)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Grade III</td><td align="left" colspan="1" rowspan="1">8 (19.05)</td><td align="left" colspan="1" rowspan="1">9 (19.15)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Serum urea nitrogen (mmol/L)</td><td align="left" colspan="1" rowspan="1">4.63&#8201;&#177;&#8201;1.12</td><td align="left" colspan="1" rowspan="1">4.65&#8201;&#177;&#8201;1.24</td><td align="left" colspan="1" rowspan="1">0.936</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum creatinine (&#956;mol/L)</td><td align="left" colspan="1" rowspan="1">68.16&#8201;&#177;&#8201;6.15</td><td align="left" colspan="1" rowspan="1">69.49&#8201;&#177;&#8201;5.34</td><td align="left" colspan="1" rowspan="1">0.278</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum total cholesterol (mmol/L)</td><td align="left" colspan="1" rowspan="1">3.24&#8201;&#177;&#8201;0.77</td><td align="left" colspan="1" rowspan="1">3.21&#8201;&#177;&#8201;0.79</td><td align="left" colspan="1" rowspan="1">0.856</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum triglycerides (mmol/L)</td><td align="left" colspan="1" rowspan="1">1.17&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">1.18&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">0.746</td></tr><tr><td align="left" colspan="1" rowspan="1">Alanine aminotransferase (U/L)</td><td align="left" colspan="1" rowspan="1">22.88&#8201;&#177;&#8201;4.62</td><td align="left" colspan="1" rowspan="1">23.15&#8201;&#177;&#8201;4.75</td><td align="left" colspan="1" rowspan="1">0.787</td></tr><tr><td align="left" colspan="1" rowspan="1">Aspartate aminotransferase (U/L)</td><td align="left" colspan="1" rowspan="1">22.64&#8201;&#177;&#8201;3.24</td><td align="left" colspan="1" rowspan="1">22.48&#8201;&#177;&#8201;3.20</td><td align="left" colspan="1" rowspan="1">0.818</td></tr><tr><td align="left" colspan="1" rowspan="1">Smoking history</td><td align="left" colspan="1" rowspan="1">20 (47.62)</td><td align="left" colspan="1" rowspan="1">17 (36.17)</td><td align="left" colspan="1" rowspan="1">0.274</td></tr><tr><td align="left" colspan="1" rowspan="1">Alcohol consumption history</td><td align="left" colspan="1" rowspan="1">18 (42.86)</td><td align="left" colspan="1" rowspan="1">22 (48.89)</td><td align="left" colspan="1" rowspan="1">0..573</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec14"><title>Neurological functions</title><p id="Par29">Compared with the pre-treatment period, the NIHSS scores were significantly lower at 7&#160;days post-treatment, and the NIHSS score in the observation group was lower than that in the control group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Comparison of neurological function between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">NIHSS score</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Pre-treatment</td><td align="left" colspan="1" rowspan="1">34.19&#8201;&#177;&#8201;2.41</td><td align="left" colspan="1" rowspan="1">34.49&#8201;&#177;&#8201;2.24</td><td align="left" colspan="1" rowspan="1">0.546</td></tr><tr><td align="left" colspan="1" rowspan="1">7&#160;days post-treatment</td><td align="left" colspan="1" rowspan="1">17.21&#8201;&#177;&#8201;1.87*</td><td align="left" colspan="1" rowspan="1">14.45&#8201;&#177;&#8201;1.33*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>Note: * indicates <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 compared to pretreatment in the same group</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec15"><title>Oxidative stress levels</title><p id="Par30">MDA is one of the final metabolic products of lipid peroxidation, and the level of MDA in plasma can reflect the severity of cell membrane damage caused by free radicals, indirectly reflecting the production of free radicals during ischemia&#8211;reperfusion. SOD belongs to the metalloproteinase family and plays an important role in scavenging reactive oxygen species and protecting tissues from damage. SOD can scavenge superoxide anions and protect cells from damage, and its activity reflects the ability to scavenge free radicals in tissues. SOD and MDA play crucial roles in the body&#8217;s oxidative and antioxidant balance (Yin et al. <xref ref-type="bibr" rid="CR31">2019</xref>; Li et al. <xref ref-type="bibr" rid="CR14">2022</xref>). Therefore, we observed the oxidative stress levels pre- and post-treatment in both groups. The results showed that compared with pre-treatment, the SOD levels increased and the MDA levels decreased at 7&#160;days post-treatment, and higher SOD levels and lower MDA levels were noted in the observation group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Comparison of oxidative stress levels between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Index</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">SOD (kU/L)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pre-treatment</td><td align="left" colspan="1" rowspan="1">73.56&#8201;&#177;&#8201;6.42</td><td align="left" colspan="1" rowspan="1">73.16&#8201;&#177;&#8201;6.30</td><td align="left" colspan="1" rowspan="1">0.768</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;7&#160;days post-treatment</td><td align="left" colspan="1" rowspan="1">94.35&#8201;&#177;&#8201;4.22*</td><td align="left" colspan="1" rowspan="1">97.64&#8201;&#177;&#8201;1.26*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">MDA (&#956;mol/L)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pre-treatment</td><td align="left" colspan="1" rowspan="1">7.48&#8201;&#177;&#8201;1.30</td><td align="left" colspan="1" rowspan="1">7.16&#8201;&#177;&#8201;1.33</td><td align="left" colspan="1" rowspan="1">0.254</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;7&#160;days post-treatment</td><td align="left" colspan="1" rowspan="1">6.29&#8201;&#177;&#8201;1.06*</td><td align="left" colspan="1" rowspan="1">5.18&#8201;&#177;&#8201;0.54*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>* indicates <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 compared to pretreatment in the same group</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec16"><title>Surgical-related indicator</title><p id="Par31">The observation group had less intraoperative bleeding, operation time, and hospitalization time than the control group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Comparison of surgical-related indicators between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Index</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Intraoperative bleeding (mL)</td><td align="left" colspan="1" rowspan="1">142.60&#8201;&#177;&#8201;9.40</td><td align="left" colspan="1" rowspan="1">84.26&#8201;&#177;&#8201;5.67</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Operation time (min)</td><td align="left" colspan="1" rowspan="1">140.30&#8201;&#177;&#8201;7.64</td><td align="left" colspan="1" rowspan="1">88.43&#8201;&#177;&#8201;6.32</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hospitalization time (day)</td><td align="left" colspan="1" rowspan="1">17.57&#8201;&#177;&#8201;3.09</td><td align="left" colspan="1" rowspan="1">13.11&#8201;&#177;&#8201;2.66</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Vascular endothelial function</title><p id="Par32">NO is an essential vasodilator that plays an important role in regulating vascular tone and blood flow. A decrease in NO bioavailability can lead to endothelial vasodilation dysfunction (Taneja et al. <xref ref-type="bibr" rid="CR24">2019</xref>). ET-1 is mainly produced by vascular endothelium and has a strong vasoconstrictive effect. The level of ET-1 can be used to determine endothelial function (Chuljerm et al. <xref ref-type="bibr" rid="CR4">2025</xref>). vWF is a mediator of platelet adhesion to the vascular wall and a key component of thrombosis, released into the blood by endothelial cells. Elevated vWF levels may indicate endothelial activation and dysfunction (Vischer <xref ref-type="bibr" rid="CR26">2006</xref>). Therefore, we observed the levels of vWF, ET-1, and NO pre- and post-treatment. The results showed that compared with pre-treatment, the vWF and ET-1 levels decreased, whereas NO levels increased at 3&#160;months post-treatment. Moreover, the observation group had lower levels of vWF and ET-1 and a higher level of NO, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>).
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Comparison of vascular endothelial function between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Index</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">vWF (ng/mL)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pre-treatment</td><td align="left" colspan="1" rowspan="1">116.50&#8201;&#177;&#8201;25.74</td><td align="left" colspan="1" rowspan="1">117.30&#8201;&#177;&#8201;25.32</td><td align="left" colspan="1" rowspan="1">0.877</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3&#160;months post-treatment</td><td align="left" colspan="1" rowspan="1">92.16&#8201;&#177;&#8201;20.36*</td><td align="left" colspan="1" rowspan="1">70.33&#8201;&#177;&#8201;16.42*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">ET-1 (pg/mL)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pre-treatment</td><td align="left" colspan="1" rowspan="1">77.56&#8201;&#177;&#8201;13.54</td><td align="left" colspan="1" rowspan="1">78.26&#8201;&#177;&#8201;13.96</td><td align="left" colspan="1" rowspan="1">0.811</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3&#160;months post-treatment</td><td align="left" colspan="1" rowspan="1">54.67&#8201;&#177;&#8201;11.06*</td><td align="left" colspan="1" rowspan="1">43.95&#8201;&#177;&#8201;10.13*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">NO (&#956;mol/L)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pre-treatment</td><td align="left" colspan="1" rowspan="1">54.96&#8201;&#177;&#8201;11.25</td><td align="left" colspan="1" rowspan="1">53.17&#8201;&#177;&#8201;12.06</td><td align="left" colspan="1" rowspan="1">0.473</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3&#160;months post-treatment</td><td align="left" colspan="1" rowspan="1">71.26&#8201;&#177;&#8201;14.85*</td><td align="left" colspan="1" rowspan="1">82.52&#8201;&#177;&#8201;13.57*</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>* indicates <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 compared to pretreatment in the same group</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec18"><title>Postoperative complications</title><p id="Par33">The incidence of postoperative complications was higher in the control group (23.81%) than in the observation group (8.51%), with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;=&#8201;0.048). All patients were discharged post-treatment (Table&#160;<xref rid="Tab6" ref-type="table">6</xref>).
<table-wrap id="Tab6" position="float" orientation="portrait"><label>Table 6</label><caption><p>Comparison of postoperative complications between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Complications</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Hyponatremia (serum sodium concentration&#8201;&lt;&#8201;135&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">3 (7.14)</td><td align="left" colspan="1" rowspan="1">2 (4.26)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Cerebral vasospasm</td><td align="left" colspan="1" rowspan="1">3 (7.14)</td><td align="left" colspan="1" rowspan="1">0 (0.00)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Hydrocephalus</td><td align="left" colspan="1" rowspan="1">1 (2.38)</td><td align="left" colspan="1" rowspan="1">0 (0.00)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Rebleeding</td><td align="left" colspan="1" rowspan="1">3 (7.14)</td><td align="left" colspan="1" rowspan="1">2 (4.26)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Total incidence</td><td align="left" colspan="1" rowspan="1">10 (23.81)</td><td align="left" colspan="1" rowspan="1">4 (8.51)</td><td align="left" colspan="1" rowspan="1">0.048</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec19"><title>Efficacy</title><p id="Par34">The total response rate in the control group was 66.67%, while that in the observation group was 85.11%. The treatment effect in the observation group was significantly superior to that in the control group, with a statistically significant difference (<italic toggle="yes">P</italic>&#8201;=&#8201;0.041) (Table&#160;<xref rid="Tab7" ref-type="table">7</xref>).
<table-wrap id="Tab7" position="float" orientation="portrait"><label>Table 7</label><caption><p>Comparison of therapeutic efficacy between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Efficacy</th><th align="left" colspan="1" rowspan="1">Control group (<italic toggle="yes">n</italic>&#8201;=&#8201;42)</th><th align="left" colspan="1" rowspan="1">Observation group (<italic toggle="yes">n</italic>&#8201;=&#8201;47)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Markedly effective</td><td align="left" colspan="1" rowspan="1">15 (35.71)</td><td align="left" colspan="1" rowspan="1">23 (48.94)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Effective</td><td align="left" colspan="1" rowspan="1">13 (30.95)</td><td align="left" colspan="1" rowspan="1">17 (36.17)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Ineffective</td><td align="left" colspan="1" rowspan="1">14 (33.33)</td><td align="left" colspan="1" rowspan="1">7 (14.89)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Total effective rate</td><td align="left" colspan="1" rowspan="1">28 (66.67)</td><td align="left" colspan="1" rowspan="1">40 (85.11)</td><td align="left" colspan="1" rowspan="1">0.041</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec20"><title>Discussion</title><p id="Par35">Common symptoms of IAs include intense headaches and hemifacial numbness, often associated with high mortality and disability rates. Consequently, early surgical intervention is crucial to enhance patient recovery and improve long-term outcomes (Li et al. <xref ref-type="bibr" rid="CR13">2023</xref>). The aim of this study was to investigate the efficacy analysis of endovascular embolization for RIAs. It was found that endovascular embolization was more effective in the treatment of RIAs, reducing oxidative stress and vascular endothelial injury, with shorter procedures and hospital stays than microscopic aneurysm clamping.</p><p id="Par36">First of all, this study found that after endovascular embolization treatment, the neurological function impairment of patients with RIAs was significantly improved. Specifically, the patients&#8217; neurological function scores were significantly improved compared with the preoperative scores, which indicated that endovascular embolization had a positive effect in protecting brain tissue and improving neurological function. Relevant literature has also shown that endovascular therapy has demonstrated the ability to improve NIHSS and mRS scores in patients with mild ischemic stroke and large infarct cores, making it a viable treatment option for clinical use (Kou et al. <xref ref-type="bibr" rid="CR10">2022</xref>). Besides, in the study by Song et al. involving 120 patients with large ischemic stroke, 92 (76.7%) underwent endovascular thrombectomy, whereas 28 (23.3%) received standard medical therapy. Endovascular thrombectomy was found to significantly improve mRS scores compared to standard medical therapy (Song et al. <xref ref-type="bibr" rid="CR22">2023</xref>).</p><p id="Par37">In the present study, we found that endovascular embolization not only significantly reduced oxidative stress in patients with RIAs, but this effect may be attributed to the minimally invasive nature of the procedure, which imposes a lower overall burden on the body. The study showed that endovascular embolization was significantly better than microscopic aneurysm clamping in reducing endothelial injury. Markers related to endothelial injury (e.g., vWF, ET-1) were significantly lower in the endovascular treatment group, showing better vascular protection. The study by Kerzmann et al. suggests that compared to conventional surgery, endovascular treatment is less invasive and has become more effective due to the development of advanced techniques and devices (Kerzmann et al. <xref ref-type="bibr" rid="CR9">2020</xref>). This result is consistent with the results of the present study and further validates the effectiveness of endovascular therapy in reducing surgery-induced oxidative stress. This study also found that endovascular embolization reduced intraoperative bleeding, shortened operative time, and significantly reduced hospitalization. As previously reported, patients treated with endovascular therapy within 6 to 16&#160;h of stroke onset experience better quality of life, including enhanced mobility, greater social participation, improved cognitive function, and reduced depression, compared to those receiving only medical therapy (Polding et al. <xref ref-type="bibr" rid="CR18">2021</xref>). This is also in line with the observations of this study, which demonstrate the advantages of endovascular therapy in improving patients&#8217; quality of life and reducing the consumption of healthcare resources.</p><p id="Par38">As previously mentioned, endovascular embolization intervention has become the standard method for treating both RIA and unruptured intracranial aneurysms due to its minimally invasive advantages and increasingly widespread application (Opitz et al. <xref ref-type="bibr" rid="CR16">2023</xref>). Based on the results of this study, the minimally invasive advantages of endovascular embolization for treating RIA can be explained through multiple mechanisms: it may rapidly block blood flow impact by precisely filling the aneurysm cavity, significantly reducing intraoperative bleeding and surgical time (in this study, both intraoperative bleeding and surgical time were lower in the observation group than in the control group), avoiding direct traction damage to brain tissue caused by craniotomy, and thereby reducing secondary oxidative stress reactions (e.g., in this study, SOD levels increased and MDA levels decreased on day 7 postoperatively in the observation group, consistent with the positive effects of minimally invasive techniques on reducing oxidative stress reported by Xia et al. (Xia et al. <xref ref-type="bibr" rid="CR29">2019</xref>)). Meanwhile, endovascular treatment effectively blocks the &#8220;oxidative stress-inflammation-vasospasm&#8221; vicious cycle by protecting vascular endothelial function (increased NO and decreased ET-1 in the observation group) and inhibiting inflammatory factor release (lower vWF levels), which aligns with the key point proposed by Iqbal et al. (Ahmed et al. <xref ref-type="bibr" rid="CR2">2024</xref>) that endothelial protection is a crucial aspect of minimally invasive techniques. This subsequently shortens hospital stays and reduces complication rates (in this study, both hospital stay duration and complication rates were better in the observation group than in the control group), ultimately leading to faster neurological recovery (lower NIHSS scores) and improved clinical outcomes (higher effectiveness rate in the observation group). These potential mechanisms collectively support the rationality of endovascular embolization as the preferred treatment option for RIAs. Further research is needed to explore its specific mechanisms of action in the future.</p><p id="Par39">In summary, the results of this study support endovascular embolization as an effective means of RIA treatment. Endovascular embolization provides a safer and more efficient treatment option for patients with RIAs. Although this study has preliminarily revealed the regulatory effect of endovascular coiling on oxidative stress in ruptured intracranial aneurysms, it still has the following limitations: it did not systematically evaluate the direct damaging effects of extracellular hemoglobin accumulation on oxidative stress after SAH; it did not simultaneously detect inflammatory markers and NO synthase isoforms, making it difficult to accurately distinguish the association between NO sources and endothelial function improvement; it lacked healthy controls and unruptured aneurysm subgroups, limiting the generalizability of the results; venous blood testing could not reflect the local oxidative stress status in the brain, and the use of endothelin receptor antagonists in patients with vasospasm in the control group may have interfered with indicator comparisons. Future research could focus on multidimensional integration by including healthy controls and unruptured aneurysm subgroups, precisely monitoring local oxidative stress markers in the brain using cerebrospinal fluid microdialysis technology, simultaneously detecting inflammatory factors and NO synthase isoforms to clarify NO sources, and designing multicenter randomized controlled trials to standardize control group interventions, thereby systematically revealing the oxidative stress regulatory mechanisms of endovascular coiling in repairing ruptured aneurysms and providing high-level evidence for optimizing clinical treatment strategies.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Sheng Yang and Shanwu Wu are co-first authors.</p></fn></fn-group><notes notes-type="author-contribution"><title>Authors'contributions</title><p>SY finished the study design and the experimental studies. SWW finished the data analysis. YGO finished the manuscript editing. All authors read and approved the final manuscript.
</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The work was not funded by any funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The experimental data used to support the findings of this study are available from the corresponding author upon request.
</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethical approval and consent to participate</title><p id="Par40">This study was ratified by the Ethics Committee of Puren Hospital Affiliated to Wuhan University of Science and Technology. The patients provided their written informed consent for this study.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par41">Patients signed informed consent regarding publishing their data and photographs.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests
</title><p id="Par42">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="other"> Aguilar Diaz De Leon, J. and C.R. Borges, Evaluation of Oxidative stress in biological samples using the thiobarbituric acid reactive substances assay<italic toggle="yes">.</italic> J Vis Exp, 2020(159).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3791/61122</pub-id><pub-id pub-id-type="pmcid">PMC9617585</pub-id><pub-id pub-id-type="pmid">32478759</pub-id></mixed-citation></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>IIK</given-names></name><name name-style="western"><surname>Sheybani</surname><given-names>A</given-names></name><name name-style="western"><surname>De Francesco</surname><given-names>T</given-names></name><name name-style="western"><surname>Samuelson</surname><given-names>TW</given-names></name></person-group><article-title>Corneal endothelial safety profile in minimally invasive glaucoma surgery</article-title><source>J Cataract Refract Surg</source><year>2024</year><volume>50</volume><issue>4</issue><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">37988037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.jcrs.0000000000001365</pub-id><pub-id pub-id-type="pmcid">PMC10959532</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ahmed IIK, Sheybani A, De Francesco T, Samuelson TW. Corneal endothelial safety profile in minimally invasive glaucoma surgery. J Cataract Refract Surg. 2024;50(4):369&#8211;77.<pub-id pub-id-type="pmid">37988037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.jcrs.0000000000001365</pub-id><pub-id pub-id-type="pmcid">PMC10959532</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benson</surname><given-names>RE</given-names></name><name name-style="western"><surname>Catalfamo</surname><given-names>JL</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>M</given-names></name><name name-style="western"><surname>Dodds</surname><given-names>WJ</given-names></name></person-group><article-title>A sensitive immunoassay for von Willebrand factor</article-title><source>J Immunoassay</source><year>1991</year><volume>12</volume><issue>3</issue><fpage>371</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">1939665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01971529108055078</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Benson RE, Catalfamo JL, Brooks M, Dodds WJ. A sensitive immunoassay for von Willebrand factor. J Immunoassay. 1991;12(3):371&#8211;90.<pub-id pub-id-type="pmid">1939665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01971529108055078</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuljerm</surname><given-names>H</given-names></name><name name-style="western"><surname>Maneekesorn</surname><given-names>S</given-names></name><name name-style="western"><surname>Thorup</surname><given-names>G</given-names></name><name name-style="western"><surname>Nantakool</surname><given-names>S</given-names></name><name name-style="western"><surname>Charoenkwan</surname><given-names>P</given-names></name><name name-style="western"><surname>Rerkasem</surname><given-names>K</given-names></name></person-group><article-title>The relevance of endothelial dysfunction biomarkers in thalassemia patients and healthy individuals: a systematic review and meta-analysis</article-title><source>Int J Mol Sci</source><year>2025</year><pub-id pub-id-type="doi">10.3390/ijms26083842</pub-id><pub-id pub-id-type="pmid">40332500</pub-id><pub-id pub-id-type="pmcid">PMC12027490</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Chuljerm H, Maneekesorn S, Thorup G, Nantakool S, Charoenkwan P, Rerkasem K. The relevance of endothelial dysfunction biomarkers in thalassemia patients and healthy individuals: a systematic review and meta-analysis. Int J Mol Sci. 2025. 10.3390/ijms26083842.<pub-id pub-id-type="pmid">40332500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms26083842</pub-id><pub-id pub-id-type="pmcid">PMC12027490</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><mixed-citation publication-type="other"> Chumnanvej, S., I.F. Dunn, and D.H. Kim, Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage<italic toggle="yes">.</italic> Neurosurgery, 2007. 60(1):99&#8211;102; discussion 102&#8211;3.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1227/01.NEU.0000249207.66225.D9</pub-id><pub-id pub-id-type="pmid">17228257</pub-id></mixed-citation></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feoli</surname><given-names>AM</given-names></name><name name-style="western"><surname>Macagnan</surname><given-names>FE</given-names></name><name name-style="western"><surname>Piovesan</surname><given-names>CH</given-names></name><name name-style="western"><surname>Bodanese</surname><given-names>LC</given-names></name><name name-style="western"><surname>Siqueira</surname><given-names>IR</given-names></name></person-group><article-title>Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session</article-title><source>Oxid Med Cell Longev</source><year>2014</year><volume>2014</volume><fpage>587083</fpage><pub-id pub-id-type="pmid">24967004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/587083</pub-id><pub-id pub-id-type="pmcid">PMC4055370</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Feoli AM, Macagnan FE, Piovesan CH, Bodanese LC, Siqueira IR. Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session. Oxid Med Cell Longev. 2014;2014: 587083.<pub-id pub-id-type="pmid">24967004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/587083</pub-id><pub-id pub-id-type="pmcid">PMC4055370</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goshi</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>G</given-names></name><name name-style="western"><surname>He</surname><given-names>Q</given-names></name></person-group><article-title>Nitric oxide detection methods in vitro and in vivo</article-title><source>Med Gas Res</source><year>2019</year><volume>9</volume><issue>4</issue><fpage>192</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">31898604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/2045-9912.273957</pub-id><pub-id pub-id-type="pmcid">PMC7802420</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Goshi E, Zhou G, He Q. Nitric oxide detection methods in vitro and in vivo. Med Gas Res. 2019;9(4):192&#8211;207.<pub-id pub-id-type="pmid">31898604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/2045-9912.273957</pub-id><pub-id pub-id-type="pmcid">PMC7802420</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez-Navarro</surname><given-names>I</given-names></name><name name-style="western"><surname>Botana</surname><given-names>L</given-names></name><name name-style="western"><surname>Diez-Mata</surname><given-names>J</given-names></name><name name-style="western"><surname>Tesoro</surname><given-names>L</given-names></name><name name-style="western"><surname>Jimenez-Guirado</surname><given-names>B</given-names></name><name name-style="western"><surname>Gonzalez-Cucharero</surname><given-names>C</given-names></name><etal/></person-group><article-title>Replicative endothelial cell senescence may lead to endothelial dysfunction by increasing the BH2/BH4 ratio induced by oxidative stress, reducing BH4 availability, and decreasing the expression of eNOS</article-title><source>Int J Mol Sci</source><year>2024</year><pub-id pub-id-type="doi">10.3390/ijms25189890</pub-id><pub-id pub-id-type="pmid">39337378</pub-id><pub-id pub-id-type="pmcid">PMC11432946</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Hernandez-Navarro I, Botana L, Diez-Mata J, Tesoro L, Jimenez-Guirado B, Gonzalez-Cucharero C, et al. Replicative endothelial cell senescence may lead to endothelial dysfunction by increasing the BH2/BH4 ratio induced by oxidative stress, reducing BH4 availability, and decreasing the expression of eNOS. Int J Mol Sci. 2024. 10.3390/ijms25189890.<pub-id pub-id-type="pmid">39337378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms25189890</pub-id><pub-id pub-id-type="pmcid">PMC11432946</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerzmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Boesmans</surname><given-names>E</given-names></name><name name-style="western"><surname>Holemans</surname><given-names>C</given-names></name><name name-style="western"><surname>Quaniers</surname><given-names>J</given-names></name><name name-style="western"><surname>Alexandrescu</surname><given-names>V</given-names></name><name name-style="western"><surname>Defraigne</surname><given-names>JO</given-names></name></person-group><article-title>Endovascular treatment of femoropopliteal arterial occlusive disease</article-title><source>Rev Med Liege</source><year>2020</year><volume>75</volume><issue>11</issue><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">33155445</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kerzmann A, Boesmans E, Holemans C, Quaniers J, Alexandrescu V, Defraigne JO. Endovascular treatment of femoropopliteal arterial occlusive disease. Rev Med Liege. 2020;75(11):717&#8211;23.<pub-id pub-id-type="pmid">33155445</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kou</surname><given-names>WH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>JS</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>N</given-names></name><name name-style="western"><surname>Nie</surname><given-names>XH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Endovascular treatment vs drug therapy alone in patients with mild ischemic stroke and large infarct cores</article-title><source>World J Clin Cases</source><year>2022</year><volume>10</volume><issue>28</issue><fpage>10077</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">36246812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12998/wjcc.v10.i28.10077</pub-id><pub-id pub-id-type="pmcid">PMC9561577</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kou WH, Wang XQ, Yang JS, Qiao N, Nie XH, Yu AM, et al. Endovascular treatment vs drug therapy alone in patients with mild ischemic stroke and large infarct cores. World J Clin Cases. 2022;10(28):10077&#8211;84.<pub-id pub-id-type="pmid">36246812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12998/wjcc.v10.i28.10077</pub-id><pub-id pub-id-type="pmcid">PMC9561577</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwah</surname><given-names>LK</given-names></name><name name-style="western"><surname>Diong</surname><given-names>J</given-names></name></person-group><article-title>National Institutes of Health Stroke Scale (NIHSS)</article-title><source>J Physiother</source><year>2014</year><volume>60</volume><issue>1</issue><fpage>61</fpage><pub-id pub-id-type="doi">10.1016/j.jphys.2013.12.012</pub-id><pub-id pub-id-type="pmid">24856948</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014;60(1):61.<pub-id pub-id-type="pmid">24856948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jphys.2013.12.012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Su</surname><given-names>Z</given-names></name><name name-style="western"><surname>Su</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>Profiling of immune infiltration landscape of ruptured intracranial aneurysm</article-title><source>Medicine (Baltimore)</source><year>2024</year><volume>103</volume><issue>12</issue><fpage>e37523</fpage><pub-id pub-id-type="pmid">38518032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000037523</pub-id><pub-id pub-id-type="pmcid">PMC10957028</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Li C, Su Z, Su W, Wang Q, Wang S, Li Z. Profiling of immune infiltration landscape of ruptured intracranial aneurysm. Medicine (Baltimore). 2024;103(12): e37523.<pub-id pub-id-type="pmid">38518032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000037523</pub-id><pub-id pub-id-type="pmcid">PMC10957028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W</given-names></name><name name-style="western"><surname>Ji</surname><given-names>P</given-names></name></person-group><article-title>Comparative study on the clinical outcomes and prognosis of endovascular embolization and craniotomy clipping for the treatment of cerebral aneurysms</article-title><source>Pak J Med Sci</source><year>2023</year><volume>39</volume><issue>5</issue><fpage>1296</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">37680810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.39.5.7401</pub-id><pub-id pub-id-type="pmcid">PMC10480711</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Li G, Chen S, Han J, Pan W, Ji P. Comparative study on the clinical outcomes and prognosis of endovascular embolization and craniotomy clipping for the treatment of cerebral aneurysms. Pak J Med Sci. 2023;39(5):1296&#8211;300.<pub-id pub-id-type="pmid">37680810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.39.5.7401</pub-id><pub-id pub-id-type="pmcid">PMC10480711</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Somasodiran</surname><given-names>M</given-names></name><name name-style="western"><surname>Sun</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Long</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name></person-group><article-title>Efficacy of low extra-abdominal aortic block in cesarean section for placenta accreta spectrum disorders and its effect on the expression of MDA and SOD</article-title><source>Zhong Nan Da Xue Xue Bao Yi Xue Ban</source><year>2022</year><volume>47</volume><issue>8</issue><fpage>1129</fpage><lpage>1135</lpage><pub-id pub-id-type="pmid">36097781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.11817/j.issn.1672-7347.2022.220118</pub-id><pub-id pub-id-type="pmcid">PMC10950110</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Li R, Somasodiran M, Sun T, Chen C, Long M, Xu D. Efficacy of low extra-abdominal aortic block in cesarean section for placenta accreta spectrum disorders and its effect on the expression of MDA and SOD. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(8):1129&#8211;35.<pub-id pub-id-type="pmid">36097781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.11817/j.issn.1672-7347.2022.220118</pub-id><pub-id pub-id-type="pmcid">PMC10950110</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morel</surname><given-names>S</given-names></name><name name-style="western"><surname>Bijlenga</surname><given-names>P</given-names></name><name name-style="western"><surname>Kwak</surname><given-names>BR</given-names></name></person-group><article-title>Intracranial aneurysm wall (in)stability-current state of knowledge and clinical perspectives</article-title><source>Neurosurg Rev</source><year>2022</year><volume>45</volume><issue>2</issue><fpage>1233</fpage><lpage>1253</lpage><pub-id pub-id-type="pmid">34743248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10143-021-01672-5</pub-id><pub-id pub-id-type="pmcid">PMC8976821</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Morel S, Bijlenga P, Kwak BR. Intracranial aneurysm wall (in)stability-current state of knowledge and clinical perspectives. Neurosurg Rev. 2022;45(2):1233&#8211;53.<pub-id pub-id-type="pmid">34743248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10143-021-01672-5</pub-id><pub-id pub-id-type="pmcid">PMC8976821</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opitz</surname><given-names>M</given-names></name><name name-style="western"><surname>Zenk</surname><given-names>C</given-names></name><name name-style="western"><surname>Zensen</surname><given-names>S</given-names></name><name name-style="western"><surname>Bos</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Styczen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Radiation dose and fluoroscopy time of aneurysm coiling in patients with unruptured and ruptured intracranial aneurysms as a function of aneurysm size, location, and patient age</article-title><source>Neuroradiology</source><year>2023</year><volume>65</volume><issue>3</issue><fpage>637</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">36418556</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00234-022-03092-8</pub-id><pub-id pub-id-type="pmcid">PMC9905176</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Opitz M, Zenk C, Zensen S, Bos D, Li Y, Styczen H, et al. Radiation dose and fluoroscopy time of aneurysm coiling in patients with unruptured and ruptured intracranial aneurysms as a function of aneurysm size, location, and patient age. Neuroradiology. 2023;65(3):637&#8211;44.<pub-id pub-id-type="pmid">36418556</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00234-022-03092-8</pub-id><pub-id pub-id-type="pmcid">PMC9905176</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ping</surname><given-names>Z</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lang</surname><given-names>H</given-names></name><name name-style="western"><surname>Xinyong</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhiyi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiaocheng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Oxidative stress in radiation-induced cardiotoxicity</article-title><source>Oxid Med Cell Longev</source><year>2020</year><volume>2020</volume><fpage>3579143</fpage><pub-id pub-id-type="pmid">32190171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/3579143</pub-id><pub-id pub-id-type="pmcid">PMC7071808</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Ping Z, Peng Y, Lang H, Xinyong C, Zhiyi Z, Xiaocheng W, et al. Oxidative stress in radiation-induced cardiotoxicity. Oxid Med Cell Longev. 2020;2020:3579143.<pub-id pub-id-type="pmid">32190171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/3579143</pub-id><pub-id pub-id-type="pmcid">PMC7071808</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polding</surname><given-names>LC</given-names></name><name name-style="western"><surname>Tate</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mlynash</surname><given-names>M</given-names></name><name name-style="western"><surname>Marks</surname><given-names>MP</given-names></name><name name-style="western"><surname>Heit</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Quality of life in physical, social, and cognitive domains improves with endovascular therapy in the DEFUSE 3 trial</article-title><source>Stroke</source><year>2021</year><volume>52</volume><issue>4</issue><fpage>1185</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">33596675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.031490</pub-id><pub-id pub-id-type="pmcid">PMC7987886</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Polding LC, Tate WJ, Mlynash M, Marks MP, Heit JJ, Christensen S, et al. Quality of life in physical, social, and cognitive domains improves with endovascular therapy in the DEFUSE 3 trial. Stroke. 2021;52(4):1185&#8211;91.<pub-id pub-id-type="pmid">33596675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.031490</pub-id><pub-id pub-id-type="pmcid">PMC7987886</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santarosa</surname><given-names>C</given-names></name><name name-style="western"><surname>Cord</surname><given-names>B</given-names></name><name name-style="western"><surname>Koo</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhogal</surname><given-names>P</given-names></name><name name-style="western"><surname>Malhotra</surname><given-names>A</given-names></name><name name-style="western"><surname>Payabvash</surname><given-names>S</given-names></name><etal/></person-group><article-title>Vessel wall magnetic resonance imaging in intracranial aneurysms: principles and emerging clinical applications</article-title><source>Interv Neuroradiol</source><year>2020</year><volume>26</volume><issue>2</issue><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">31818175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1591019919891297</pub-id><pub-id pub-id-type="pmcid">PMC7507220</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Santarosa C, Cord B, Koo A, Bhogal P, Malhotra A, Payabvash S, et al. Vessel wall magnetic resonance imaging in intracranial aneurysms: principles and emerging clinical applications. Interv Neuroradiol. 2020;26(2):135&#8211;46.<pub-id pub-id-type="pmid">31818175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1591019919891297</pub-id><pub-id pub-id-type="pmcid">PMC7507220</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scerrati</surname><given-names>A</given-names></name><name name-style="western"><surname>Visani</surname><given-names>J</given-names></name><name name-style="western"><surname>Flacco</surname><given-names>ME</given-names></name><name name-style="western"><surname>Ricciardi</surname><given-names>L</given-names></name><name name-style="western"><surname>Trungu</surname><given-names>S</given-names></name><name name-style="western"><surname>Raco</surname><given-names>A</given-names></name><etal/></person-group><article-title>Endovascular treatment of ruptured intracranial blister aneurysms: a systematic review and meta-analysis</article-title><source>AJNR Am J Neuroradiol</source><year>2021</year><volume>42</volume><issue>3</issue><fpage>538</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">33361375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3174/ajnr.A6924</pub-id><pub-id pub-id-type="pmcid">PMC7959417</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Scerrati A, Visani J, Flacco ME, Ricciardi L, Trungu S, Raco A, et al. Endovascular treatment of ruptured intracranial blister aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2021;42(3):538&#8211;45.<pub-id pub-id-type="pmid">33361375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3174/ajnr.A6924</pub-id><pub-id pub-id-type="pmcid">PMC7959417</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>SG</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>M</given-names></name><name name-style="western"><surname>Casty</surname><given-names>A</given-names></name></person-group><article-title>Critical factors in the radioimmunoassay of endothelin-1, endothelin-3, and big endothelin-1 in human plasma</article-title><source>Anal Biochem</source><year>2000</year><volume>278</volume><issue>2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">10660455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/abio.1999.4451</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Shaw SG, Schmid M, Casty A. Critical factors in the radioimmunoassay of endothelin-1, endothelin-3, and big endothelin-1 in human plasma. Anal Biochem. 2000;278(2):143&#8211;9.<pub-id pub-id-type="pmid">10660455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/abio.1999.4451</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yue</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Locked-in syndrome responding to endovascular treatment</article-title><source>J Neurointerv Surg</source><year>2023</year><volume>15</volume><issue>8</issue><fpage>808</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">35985839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnis-2022-019112</pub-id><pub-id pub-id-type="pmcid">PMC10359522</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Song J, Huang J, Li L, Yang J, Yue C, Liu S, et al. Locked-in syndrome responding to endovascular treatment. J Neurointerv Surg. 2023;15(8):808&#8211;13.<pub-id pub-id-type="pmid">35985839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnis-2022-019112</pub-id><pub-id pub-id-type="pmcid">PMC10359522</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabaei</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>M</given-names></name></person-group><article-title>Enzyme-linked immunosorbent assay (ELISA)</article-title><source>Methods Mol Biol</source><year>2022</year><volume>2508</volume><fpage>115</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">35737237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-2376-3_10</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Tabatabaei MS, Ahmed M. Enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol. 2022;2508:115&#8211;34.<pub-id pub-id-type="pmid">35737237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-2376-3_10</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taneja</surname><given-names>G</given-names></name><name name-style="western"><surname>Sud</surname><given-names>A</given-names></name><name name-style="western"><surname>Pendse</surname><given-names>N</given-names></name><name name-style="western"><surname>Panigrahi</surname><given-names>B</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>AK</given-names></name></person-group><article-title>Nano-medicine and vascular endothelial dysfunction: options and delivery strategies</article-title><source>Cardiovasc Toxicol</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">30448914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12012-018-9491-x</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Taneja G, Sud A, Pendse N, Panigrahi B, Kumar A, Sharma AK. Nano-medicine and vascular endothelial dysfunction: options and delivery strategies. Cardiovasc Toxicol. 2019;19(1):1&#8211;12.<pub-id pub-id-type="pmid">30448914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12012-018-9491-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>N</given-names></name><name name-style="western"><surname>Gan</surname><given-names>N</given-names></name><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Su</surname><given-names>F</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Effects of butylphthalide combined with fasudil on inflammatory factors, cognitive function and vascular endothelial function in patients with subarachnoid hemorrhage complicated with cerebral vasospasm</article-title><source>Pak J Med Sci</source><year>2023</year><volume>39</volume><issue>6</issue><fpage>1737</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">37936735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.39.6.6768</pub-id><pub-id pub-id-type="pmcid">PMC10626066</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Tian N, Gan N, Song C, Su F, Xie J, Zhang Y. Effects of butylphthalide combined with fasudil on inflammatory factors, cognitive function and vascular endothelial function in patients with subarachnoid hemorrhage complicated with cerebral vasospasm. Pak J Med Sci. 2023;39(6):1737&#8211;41.<pub-id pub-id-type="pmid">37936735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.39.6.6768</pub-id><pub-id pub-id-type="pmcid">PMC10626066</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vischer</surname><given-names>UM</given-names></name></person-group><article-title>Von Willebrand factor, endothelial dysfunction, and cardiovascular disease</article-title><source>J Thromb Haemost</source><year>2006</year><volume>4</volume><issue>6</issue><fpage>1186</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16706957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1538-7836.2006.01949.x</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Vischer UM. Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4(6):1186&#8211;93.<pub-id pub-id-type="pmid">16706957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1538-7836.2006.01949.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Li</surname><given-names>CH</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JF</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>BL</given-names></name></person-group><article-title>Endovascular treatment of multiple intracranial aneurysms</article-title><source>Medicine (Baltimore)</source><year>2023</year><volume>102</volume><issue>47</issue><fpage>e36340</fpage><pub-id pub-id-type="pmid">38013257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000036340</pub-id><pub-id pub-id-type="pmcid">PMC10681595</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Wang JW, Li CH, Liu JF, Li H, Guo H, Gao BL. Endovascular treatment of multiple intracranial aneurysms. Medicine (Baltimore). 2023;102(47): e36340.<pub-id pub-id-type="pmid">38013257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000036340</pub-id><pub-id pub-id-type="pmcid">PMC10681595</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ji</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W</given-names></name><name name-style="western"><surname>Du</surname><given-names>Q</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Elevated serum NOX2 levels contribute to delayed cerebral ischemia and a poor prognosis after aneurysmal subarachnoid hemorrhage: a prospective cohort study</article-title><source>Neuropsychiatr Dis Treat</source><year>2023</year><volume>19</volume><fpage>1027</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">37153352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/NDT.S407907</pub-id><pub-id pub-id-type="pmcid">PMC10155717</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Wu X, Ji D, Wang Z, Yu W, Du Q, Hu W, et al. Elevated serum NOX2 levels contribute to delayed cerebral ischemia and a poor prognosis after aneurysmal subarachnoid hemorrhage: a prospective cohort study. Neuropsychiatr Dis Treat. 2023;19:1027&#8211;42.<pub-id pub-id-type="pmid">37153352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/NDT.S407907</pub-id><pub-id pub-id-type="pmcid">PMC10155717</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>L</given-names></name><name name-style="western"><surname>Han</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ni</surname><given-names>XY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Different techniques of minimally invasive craniopuncture for the treatment of hypertensive intracerebral hemorrhage</article-title><source>World Neurosurg</source><year>2019</year><volume>126</volume><fpage>e888</fpage><lpage>e894</lpage><pub-id pub-id-type="pmid">30872203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.wneu.2019.03.006</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Xia L, Han Q, Ni XY, Chen B, Yang X, Chen Q, et al. Different techniques of minimally invasive craniopuncture for the treatment of hypertensive intracerebral hemorrhage. World Neurosurg. 2019;126:e888&#8211;94.<pub-id pub-id-type="pmid">30872203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.wneu.2019.03.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Ocak</surname><given-names>U</given-names></name><name name-style="western"><surname>Lenahan</surname><given-names>C</given-names></name><name name-style="western"><surname>Shao</surname><given-names>A</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Melanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1alpha pathway in rats</article-title><source>Theranostics</source><year>2021</year><volume>11</volume><issue>2</issue><fpage>522</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">33391490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.49426</pub-id><pub-id pub-id-type="pmcid">PMC7738864</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Xu W, Yan J, Ocak U, Lenahan C, Shao A, Tang J, et al. Melanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1alpha pathway in rats. Theranostics. 2021;11(2):522&#8211;39.<pub-id pub-id-type="pmid">33391490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.49426</pub-id><pub-id pub-id-type="pmcid">PMC7738864</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Association between activities of SOD, MDA and Na(+)-K(+)-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia</article-title><source>Hellenic J Cardiol</source><year>2019</year><volume>60</volume><issue>6</issue><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">29702256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.hjc.2018.04.003</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Yin Y, Han W, Cao Y. Association between activities of SOD, MDA and Na(+)-K(+)-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia. Hellenic J Cardiol. 2019;60(6):366&#8211;71.<pub-id pub-id-type="pmid">29702256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.hjc.2018.04.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tan</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Use of covered stents to treat complex cerebrovascular diseases: expert consensus</article-title><source>Front Cardiovasc Med</source><year>2022</year><volume>9</volume><fpage>934496</fpage><pub-id pub-id-type="pmid">36186960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2022.934496</pub-id><pub-id pub-id-type="pmcid">PMC9524574</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Zhu Y, Tan H, Wu Z, Li T, Ma L, Liu J, et al. Use of covered stents to treat complex cerebrovascular diseases: expert consensus. Front Cardiovasc Med. 2022;9: 934496.<pub-id pub-id-type="pmid">36186960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2022.934496</pub-id><pub-id pub-id-type="pmcid">PMC9524574</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>